Here are the DEF 14A proxy statements from Boston Scientific Corporation (BSX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow BSX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BSX filings page.
Boston Scientific Corporation is asking stockholders to vote at a virtual 2026 Annual Meeting on April 30, 2026 at 8:00 a.m. Eastern Time. Holders of common stock at the close of business on March 6, 2026, when 1,486,175,167 shares were outstanding, may vote.
Stockholders are asked to elect ten directors, approve on an advisory basis the compensation of named executive officers, and ratify Ernst & Young LLP as independent auditor for the 2026 fiscal year. The Board recommends voting FOR all three items.
The agenda includes governance and capital proposals: amending the Employee Stock Purchase Plan to increase shares reserved; removing supermajority voting provisions; adding Delaware-permitted officer exculpation; and allowing stockholders holding 25% of common stock to call a special meeting. The Board supports these four proposals and recommends AGAINST a separate stockholder proposal titled “Give Shareholders the Ability to Call for a Special Shareholder Meeting.”